Doxycycline monohydrate 5 MG/ML Oral Suspension — RxCUI 1650030
RxNorm drug concept · Semantic clinical drug
RxCUI 1650030
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
40 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1650030
Official nameDoxycycline monohydrate 5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdoxycycline monohydrate 25 MG per 5 ML Oral Suspension; doxycycline monohydrate 25 MG in 5 mL Oral Suspension
FDA products mapped12
Package NDCs mapped40
Reported Medicaid activity (SDUD)41,361 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The IV form is used when you can't take medications by mouth — for example, if you're too ill, can't swallow, or your stomach isn't absorbing medicines properly. As soon as you're...
- Why am I getting doxycycline through an IV instead of just taking a pill?
- It treats a wide range of serious bacterial infections — things like Rocky Mountain spotted fever, anthrax, plague, typhus, cholera, certain sexually transmitted infections, and re...
- What infections does doxycycline injection actually treat?
🕸️ Concept Web — How Doxycycline monohydrate 5 MG/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxycycline monohydrate 5 MG/ML Oral Suspension
RxCUI 1650030 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Doxycycline
3640IN -
Doxycycline monohydrate
203122PIN
-
Doxycycline
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vibramycin
202975BN
-
Vibramycin
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxycycline Oral Suspension
371964SCDF -
Doxycycline monohydrate Oral Suspension
2647646SCDFP -
Doxycycline Oral Liquid Product
1160777SCDG -
Doxycycline Oral Product
1160778SCDG -
Doxycycline monohydrate Oral Liquid Product
2662705SCDGP -
Doxycycline monohydrate Oral Product
2661810SCDGP -
Doxycycline Oral Suspension [Vibramycin]
702295SBDF -
Doxycycline monohydrate Oral Suspension [Vibramycin]
2658725SBDFP - +5 more in this family
-
Doxycycline Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxycycline monohydrate 5 MG/ML
1650029SCDC -
Doxycycline monohydrate 5 MG/ML Oral Suspension [Vibramycin]
861061SBD -
Doxycycline monohydrate 5 MG/ML [Vibramycin]
1650033SBDC
-
Doxycycline monohydrate 5 MG/ML
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxycycline monohydrate 5 MG/ML
SCDC · 1650029 -
Doxycycline Oral Suspension
SCDF · 371964 -
Doxycycline monohydrate Oral Suspension
SCDFP · 2647646 -
Doxycycline Oral Liquid Product
SCDG · 1160777 -
Doxycycline Oral Product
SCDG · 1160778 -
Doxycycline monohydrate Oral Liquid Product
SCDGP · 2662705 -
Doxycycline monohydrate Oral Product
SCDGP · 2661810
Brand-Name Concepts
-
Doxycycline monohydrate 5 MG/ML Oral Suspension [Vibramycin]
SBD · 861061 -
Doxycycline monohydrate 5 MG/ML [Vibramycin]
SBDC · 1650033 -
Doxycycline Oral Suspension [Vibramycin]
SBDF · 702295 -
Doxycycline monohydrate Oral Suspension [Vibramycin]
SBDFP · 2658725 -
Vibramycin Oral Liquid Product
SBDG · 1186249 -
Vibramycin Oral Product
SBDG · 1186250 -
Vibramycin
BN · 202975
📦 FDA Products & Package NDCs
12 products · 40 package NDCs
40 package NDCs map to RxCUI 1650030 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62135-0417-46 | 60 mL in 1 BOTTLE, GLASS (62135-417-46) | doxycycline | Chartwell RX LLC | 2018-01-01 |
| 62135-0625-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-625-60) | Doxycycline Hyclate | Chartwell RX LLC | 2021-07-27 |
| 62135-0626-01 | 100 TABLET, FILM COATED in 1 BOTTLE (62135-626-01) | Doxycycline Hyclate | Chartwell RX LLC | 2020-09-01 |
| 62135-0626-05 | 500 TABLET, FILM COATED in 1 BOTTLE (62135-626-05) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0626-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (62135-626-10) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-12 | 120 TABLET, FILM COATED in 1 BOTTLE (62135-626-12) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-20 | 20 TABLET, FILM COATED in 1 BOTTLE (62135-626-20) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0626-23 | 210 TABLET, FILM COATED in 1 BOTTLE (62135-626-23) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-28 | 28 TABLET, FILM COATED in 1 BOTTLE (62135-626-28) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-31 | 300 TABLET, FILM COATED in 1 BOTTLE (62135-626-31) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-40 | 400 TABLET, FILM COATED in 1 BOTTLE (62135-626-40) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-50 | 50 TABLET, FILM COATED in 1 BOTTLE (62135-626-50) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0626-96 | 2000 TABLET, FILM COATED in 1 BOTTLE (62135-626-96) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0877-46 | 60 mL in 1 BOTTLE, GLASS (62135-877-46) | doxycycline | Chartwell RX LLC | 2024-03-27 |
| 62135-0984-05 | 500 CAPSULE in 1 BOTTLE (62135-984-05) | doxycycline hyclate | Chartwell RX LLC | 2022-02-17 |
| 62135-0984-50 | 50 CAPSULE in 1 BOTTLE (62135-984-50) | doxycycline hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0985-01 | 100 CAPSULE in 1 BOTTLE (62135-985-01) | doxycycline hyclate | Chartwell RX LLC | 2020-09-01 |
| 62135-0985-05 | 500 CAPSULE in 1 BOTTLE (62135-985-05) | doxycycline hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0985-10 | 1000 CAPSULE in 1 BOTTLE (62135-985-10) | doxycycline hyclate | Chartwell RX LLC | 2020-09-01 |
| 62135-0985-50 | 50 CAPSULE in 1 BOTTLE (62135-985-50) | doxycycline hyclate | Chartwell RX LLC | 1984-09-11 |
| 68180-0657-01 | 60 mL in 1 BOTTLE (68180-657-01) | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | 2013-06-11 |
| 68999-0417-46 | 60 mL in 1 BOTTLE, GLASS (68999-417-46) | doxycycline | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0625-60 | 60 TABLET, FILM COATED in 1 BOTTLE (68999-625-60) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-02 | 20 TABLET, FILM COATED in 1 BOTTLE (68999-626-02) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2022-06-24 |
| 68999-0626-05 | 500 TABLET, FILM COATED in 1 BOTTLE (68999-626-05) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0626-06 | 100 TABLET, FILM COATED in 1 BOTTLE (68999-626-06) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2022-06-24 |
| 68999-0626-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68999-626-10) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-12 | 120 TABLET, FILM COATED in 1 BOTTLE (68999-626-12) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0626-23 | 210 TABLET, FILM COATED in 1 BOTTLE (68999-626-23) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-28 | 28 TABLET, FILM COATED in 1 BOTTLE (68999-626-28) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-30 | 30 TABLET, FILM COATED in 1 BOTTLE (68999-626-30) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-11-12 |
| 68999-0626-31 | 300 TABLET, FILM COATED in 1 BOTTLE (68999-626-31) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-40 | 400 TABLET, FILM COATED in 1 BOTTLE (68999-626-40) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-50 | 50 TABLET, FILM COATED in 1 BOTTLE (68999-626-50) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-96 | 2000 TABLET, FILM COATED in 1 BOTTLE (68999-626-96) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0984-50 | 50 CAPSULE in 1 BOTTLE (68999-984-50) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0985-01 | 100 CAPSULE in 1 BOTTLE (68999-985-01) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0985-05 | 500 CAPSULE in 1 BOTTLE (68999-985-05) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0985-10 | 1000 CAPSULE in 1 BOTTLE (68999-985-10) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0985-50 | 50 CAPSULE in 1 BOTTLE (68999-985-50) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
Observed labelers:
Chartwell RX LLC (20) ·
Chartwell Governmental & Specialty RX, LLC (19) ·
Lupin Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.